Please login to the form below

Not currently logged in
Email:
Password:

Lars Rebien Sørensen becomes chairman of Novo Holdings

He will take up the new role 1 July

Novo NordiskFormer Novo Nordisk CEO Lars Rebien Sørensen has been appointed as Novo Holdings’ new chairman.

He said: “In recent years, Novo Holdings has significantly increased its investments and influence in the global life science sector.

“I consider it to be a great responsibility to lead the continued growth of Novo Holdings as it plans to further increase its investments in life science companies in the coming years.

Sørensen will succeed Sten Scheibye - who retires effective 1 July - and he will also become chairman of the board of the Novo Nordisk Foundation.

30th May 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics